| Identification | Back Directory | [Name]
Carbamic acid, N-[(1S)-1-[3-bromo-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-, 1,1-dimethylethyl ester | [CAS]
2189684-54-4 | [Synonyms]
Carbanic acid,N-[CIS)-1-[3-bromo-6-[3-methyl-3(methyl)sulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-,1,1-dimethylethylester
Carbamic acid, N-[(1S)-1-[3-bromo-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-, 1,1-dimethylethyl ester | [Molecular Formula]
C24H27BrF2N2O4S | [MOL File]
2189684-54-4.mol | [Molecular Weight]
557.45 |
| Chemical Properties | Back Directory | [Boiling point ]
636.8±55.0 °C(Predicted) | [density ]
1.42±0.1 g/cm3(Predicted) | [pka]
10.37±0.46(Predicted) | [InChIKey]
OBUPKGOLRNAZIS-FQEVSTJZSA-N | [SMILES]
C(OC(C)(C)C)(=O)N[C@H](C1=NC(C#CC(C)(S(C)(=O)=O)C)=CC=C1Br)CC1=CC(F)=CC(F)=C1 |
| Hazard Information | Back Directory | [Description]
(S)-tert-butyl (1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate is a key pharmaceutical intermediate for lenapavir (trade name Sunlenca), used in the synthesis of anti-HIV-1 drugs. Lenapavir is a first-in-class long-acting HIV-1 capsid inhibitor administered subcutaneously, providing a prolonged treatment period, significantly reducing the treatment burden on patients, and exhibiting potent antiviral activity against drug-resistant HIV strains. | [Uses]
(S)-Tert-butyl (1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-YN-1-YL)pyridin-2-YL)-2-(3,5-difluorophenyl)ethyl)carbamate is a pharmaceutical intermediate compound that can be used in the preparation of HIV inhibitors. |
|
| Company Name: |
BOYAN PHARMA Gold
|
| Tel: |
18566078841 18566078841 |
| Website: |
boyanpharma.com/index.php?c=category&id=9 |
|